Lykis Ltd
- Market Cap ₹ 68.8 Cr.
- Current Price ₹ 35.5
- High / Low ₹ 54.0 / 25.3
- Stock P/E 70.2
- Book Value ₹ 16.9
- Dividend Yield 0.00 %
- ROCE 9.49 %
- ROE 7.01 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Debtor days have improved from 74.0 to 36.0 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Earnings include an other income of Rs.1.94 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Trading & Distributors
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119 | 167 | 104 | 106 | 148 | 146 | 84 | 59 | 317 | 432 | 371 | 264 | 237 | |
| 118 | 164 | 101 | 105 | 146 | 143 | 85 | 70 | 320 | 413 | 366 | 257 | 233 | |
| Operating Profit | 1 | 3 | 4 | 1 | 2 | 4 | -1 | -11 | -3 | 19 | 6 | 7 | 4 | 
| OPM % | 1% | 2% | 4% | 1% | 2% | 2% | -1% | -20% | -1% | 4% | 2% | 2% | 2% | 
| 2 | 1 | 1 | 3 | 3 | -1 | 2 | 1 | 6 | 3 | 3 | 3 | 2 | |
| Interest | 1 | 2 | 2 | 3 | 5 | 2 | 3 | 2 | 3 | 6 | 7 | 6 | 4 | 
| Depreciation | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 2 | 1 | 2 | 1 | 
| Profit before tax | 1 | 2 | 2 | 1 | -0 | -0 | -1 | -13 | -1 | 14 | 0 | 2 | 0 | 
| Tax % | 32% | 18% | 24% | 24% | 21% | 131% | -14% | -18% | -18% | 28% | -36% | 27% | |
| 1 | 1 | 2 | 0 | -0 | -1 | -1 | -11 | -1 | 10 | 1 | 1 | -0 | |
| EPS in Rs | 0.47 | 0.79 | 0.92 | 0.22 | -0.24 | -0.50 | -0.59 | -5.61 | -0.38 | 5.09 | 0.35 | 0.76 | -0.17 | 
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% | 
| 5 Years: | 26% | 
| 3 Years: | -6% | 
| TTM: | -36% | 
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% | 
| 5 Years: | 32% | 
| 3 Years: | 46% | 
| TTM: | -16% | 
| Stock Price CAGR | |
|---|---|
| 10 Years: | -7% | 
| 5 Years: | 5% | 
| 3 Years: | -12% | 
| 1 Year: | -23% | 
| Return on Equity | |
|---|---|
| 10 Years: | 0% | 
| 5 Years: | 0% | 
| 3 Years: | 14% | 
| Last Year: | 7% | 
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 19 | 19 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 
| Reserves | 9 | 10 | 14 | 15 | 14 | 14 | 12 | 1 | 1 | 11 | 11 | 13 | 
| 45 | 62 | 52 | 86 | 113 | 43 | 49 | 45 | 110 | 130 | 88 | 34 | |
| 6 | 10 | 24 | 10 | 43 | 36 | 11 | 26 | 10 | 10 | 17 | 12 | |
| Total Liabilities | 79 | 100 | 110 | 131 | 191 | 112 | 92 | 93 | 141 | 171 | 136 | 78 | 
| 12 | 11 | 13 | 13 | 14 | 13 | 15 | 3 | 4 | 5 | 5 | 3 | |
| CWIP | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 
| Investments | 10 | 5 | 12 | 3 | 5 | 1 | 1 | 1 | 2 | 2 | 2 | 0 | 
| 56 | 82 | 84 | 115 | 171 | 97 | 75 | 88 | 135 | 164 | 130 | 75 | |
| Total Assets | 79 | 100 | 110 | 131 | 191 | 112 | 92 | 93 | 141 | 171 | 136 | 78 | 
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -29 | -23 | 16 | -34 | 1 | 36 | 9 | -16 | -74 | -9 | 52 | 63 | |
| -11 | 4 | -8 | 9 | 0 | 2 | -2 | 9 | 10 | -0 | -1 | -5 | |
| 45 | 16 | -6 | 33 | 23 | -68 | -6 | 7 | 63 | 10 | -49 | -60 | |
| Net Cash Flow | 5 | -2 | 2 | 9 | 25 | -30 | 1 | 0 | -2 | 1 | 3 | -2 | 
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60 | 96 | 105 | 154 | 113 | 87 | 113 | 149 | 76 | 95 | 91 | 36 | 
| Inventory Days | 4 | 4 | 12 | 8 | 17 | 12 | 4 | 80 | 18 | 15 | 11 | 25 | 
| Days Payable | 12 | 17 | 10 | 20 | 17 | 43 | 25 | 53 | 11 | 6 | 11 | 13 | 
| Cash Conversion Cycle | 52 | 83 | 106 | 143 | 114 | 56 | 92 | 176 | 82 | 105 | 90 | 48 | 
| Working Capital Days | -9 | 12 | 6 | 7 | -66 | 42 | 16 | 25 | 14 | 20 | 20 | 27 | 
| ROCE % | 5% | 4% | 5% | 3% | 3% | 3% | 2% | -15% | 1% | 14% | 5% | 9% | 
Documents
Announcements
- 
        
          Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
          
            21 Oct - Postal ballot results declared Oct 21, 2025: approved material related-party transaction and excess section 186 investments/loans.
- 
        
          Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
          
            21 Oct - Postal ballot (20-21 Oct 2025): approvals for related-party deal with Lykis Exports LLC and Section 186 excess limits.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Oct
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 26 Sep
- Shareholder Meeting / Postal Ballot-Outcome of AGM 25 Sep
Annual reports
- 
    
      Financial Year 2025
      from bse
- 
    
      Financial Year 2024
      from bse
- 
    
      Financial Year 2023
      from bse
- 
    
      Financial Year 2022
      from bse
- 
    
      Financial Year 2021
      from bse
- 
    
      Financial Year 2020
      from bse
- 
    
      Financial Year 2019
      from bse
- 
    
      Financial Year 2018
      from bse
- 
    
      Financial Year 2017
      from bse
- 
    
      Financial Year 2016
      from bse
- 
    
      Financial Year 2015
      from bse
- 
    
      Financial Year 2014
      from bse
- 
    
      Financial Year 2013
      from bse
- 
    
      Financial Year 2012
      from bse
- 
    
      Financial Year 2011
      from bse
Business Overview:[1][2]
Company offers manufacturing support for private labelling in domestic and 40+ countries